Clinical Trials Directory

Trials / Completed

CompletedNCT05816811

Power Exercise for Stroke Recovery: The POWER Feasibility Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Post-stroke deficits are highly common and functional impairment persists throughout life after stroke. Skeletal muscle mass and strength are fundamental contributors to mobility throughout the adult life course. Stroke-related muscle atrophy contributes to loss of strength, and declines in lower extremity function, cardiorespiratory fitness, and walking independence and post-stroke sarcopenia. Improving the quantity and function of skeletal muscle needs to be an important therapeutic target after stroke. Resistance exercise training (RET) has been shown to increase skeletal muscle mass, strength and power, reduce oxidative stress, improve cardiac function, and better regulate lipids after stroke. However, the feasibility and the effects of a power focused RET program for individuals with stroke need to be examined.

Detailed description

This study is a single-group, open label trial examining the feasibility and preliminary effect estimates of a 10-week power-focused exercise training program in people living with stroke. Fifteen participants with chronic stroke will participate in the exercise program 3 times per week for 10 weeks at a progressive intensity. The program will take place at a community exercise gym built for older adults and people with physical disabilities. Feasibility outcomes will be assessed throughout the trial. Effectiveness outcomes will be assessed at baseline and immediately post-intervention.

Conditions

Interventions

TypeNameDescription
OTHERPower-focused resistance trainingParticipants will undergo 10 weeks of power-focused resistance training.

Timeline

Start date
2023-08-01
Primary completion
2024-05-31
Completion
2024-05-31
First posted
2023-04-18
Last updated
2024-11-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05816811. Inclusion in this directory is not an endorsement.